Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02091037 · ClinicalTrials.gov registry record

S. Aureus Colonization in Atopic Dermatitis

A clinical trial, sponsored by Columbia University.

Completed
Registry status
114
Enrollment target

NCT02091037 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 114 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02091037 has completed, sponsored by Columbia University.

COMPLETED
Registry status
114 participants
Enrollment target

Study Summary

The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing patients with atopic dermatitis will be resistant to commonly used topical antibiotic ointments.

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2011-12
Est. Completion 2017-01-11

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT02091037

The ClinicalTrials.gov registry entry for NCT02091037 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02091037 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02091037 about?

NCT02091037 is a clinical study titled "S. Aureus Colonization in Atopic Dermatitis". The purpose of this study is to characterize the bacterial strains that colonize children with atopic dermatitis. The investigators hypothesize that rectal cultures will be more sensitive than anterior nares cultures for detecting S. aureus colonization, and that strains of S. aureus colonizing pat...

What is the current status of trial NCT02091037?

This trial is currently completed. The enrollment target is 114 participants. The study started on 2011-12. Estimated completion is 2017-01-11.

Who is sponsoring clinical trial NCT02091037?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.